Transforming Hemophilia A Care: Insights into New Therapeutic Options
Hemophilia A is a hereditary bleeding disorder characterized by a deficiency in clotting factor VIII, leading to significant morbidity and a reduced quality of life. This review provides an updated overview of the current understanding of hemophilia A, highlighting its genetic underpinnings and adva...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/14/12/1568 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846103957610430464 |
|---|---|
| author | Iasmina-Maria Iurea Emilia Severin Alexandra Matei |
| author_facet | Iasmina-Maria Iurea Emilia Severin Alexandra Matei |
| author_sort | Iasmina-Maria Iurea |
| collection | DOAJ |
| description | Hemophilia A is a hereditary bleeding disorder characterized by a deficiency in clotting factor VIII, leading to significant morbidity and a reduced quality of life. This review provides an updated overview of the current understanding of hemophilia A, highlighting its genetic underpinnings and advancements in treatment strategies. A literature review was conducted using various available databases. Relevant studies on hemophilia A, covering genetics and treatment options, were selected and summarized. Recent developments in gene therapy are discussed, showcasing their potential to offer long-term solutions and reduce the burden of treatment. Additionally, the review addresses global disparities in care and policy implications, emphasizing the need for comprehensive healthcare frameworks to improve outcomes for individuals living with hemophilia A worldwide. By synthesizing recent findings and insights, this review aims to inform clinicians and policymakers about the evolving landscape of hemophilia A management and the necessity for equitable access to care. |
| format | Article |
| id | doaj-art-cb01626b95ab45aba1230a3f3354cbc7 |
| institution | Kabale University |
| issn | 2075-1729 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj-art-cb01626b95ab45aba1230a3f3354cbc72024-12-27T14:35:56ZengMDPI AGLife2075-17292024-11-011412156810.3390/life14121568Transforming Hemophilia A Care: Insights into New Therapeutic OptionsIasmina-Maria Iurea0Emilia Severin1Alexandra Matei2Genetics Department, Carol Davila University of Medicine and Pharmacy, Dionisie Lupu 37 Street, 020021 Bucharest, RomaniaGenetics Department, Carol Davila University of Medicine and Pharmacy, Dionisie Lupu 37 Street, 020021 Bucharest, RomaniaGenetics Department, Carol Davila University of Medicine and Pharmacy, Dionisie Lupu 37 Street, 020021 Bucharest, RomaniaHemophilia A is a hereditary bleeding disorder characterized by a deficiency in clotting factor VIII, leading to significant morbidity and a reduced quality of life. This review provides an updated overview of the current understanding of hemophilia A, highlighting its genetic underpinnings and advancements in treatment strategies. A literature review was conducted using various available databases. Relevant studies on hemophilia A, covering genetics and treatment options, were selected and summarized. Recent developments in gene therapy are discussed, showcasing their potential to offer long-term solutions and reduce the burden of treatment. Additionally, the review addresses global disparities in care and policy implications, emphasizing the need for comprehensive healthcare frameworks to improve outcomes for individuals living with hemophilia A worldwide. By synthesizing recent findings and insights, this review aims to inform clinicians and policymakers about the evolving landscape of hemophilia A management and the necessity for equitable access to care.https://www.mdpi.com/2075-1729/14/12/1568hemophilia Ableeding disorderhemophilia geneticsgene therapyquality of life |
| spellingShingle | Iasmina-Maria Iurea Emilia Severin Alexandra Matei Transforming Hemophilia A Care: Insights into New Therapeutic Options Life hemophilia A bleeding disorder hemophilia genetics gene therapy quality of life |
| title | Transforming Hemophilia A Care: Insights into New Therapeutic Options |
| title_full | Transforming Hemophilia A Care: Insights into New Therapeutic Options |
| title_fullStr | Transforming Hemophilia A Care: Insights into New Therapeutic Options |
| title_full_unstemmed | Transforming Hemophilia A Care: Insights into New Therapeutic Options |
| title_short | Transforming Hemophilia A Care: Insights into New Therapeutic Options |
| title_sort | transforming hemophilia a care insights into new therapeutic options |
| topic | hemophilia A bleeding disorder hemophilia genetics gene therapy quality of life |
| url | https://www.mdpi.com/2075-1729/14/12/1568 |
| work_keys_str_mv | AT iasminamariaiurea transforminghemophiliaacareinsightsintonewtherapeuticoptions AT emiliaseverin transforminghemophiliaacareinsightsintonewtherapeuticoptions AT alexandramatei transforminghemophiliaacareinsightsintonewtherapeuticoptions |